165 related articles for article (PubMed ID: 34913995)
1. Bacillibactin class of siderophore antibiotics from a marine symbiotic Bacillus as promising antibacterial agents.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Appl Microbiol Biotechnol; 2022 Jan; 106(1):329-340. PubMed ID: 34913995
[TBL] [Abstract][Full Text] [Related]
2. Polyketide-derived macrobrevins from marine macroalga-associated Bacillus amyloliquefaciens as promising antibacterial agents against pathogens causing nosocomial infections.
Chakraborty K; Kizhakkekalam VK; Joy M
Phytochemistry; 2022 Jan; 193():112983. PubMed ID: 34695706
[TBL] [Abstract][Full Text] [Related]
3. Oxygenated elansolid-type of polyketide spanned macrolides from a marine heterotrophic Bacillus as prospective antimicrobial agents against multidrug-resistant pathogens.
Kizhakkekalam VK; Chakraborty K; Joy M
Int J Antimicrob Agents; 2020 Mar; 55(3):105892. PubMed ID: 31926284
[TBL] [Abstract][Full Text] [Related]
4. Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives?
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Appl Microbiol Biotechnol; 2020 Aug; 104(16):7117-7130. PubMed ID: 32621124
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic polyketides with siderophore mode of action from marine heterotrophic Shewanella algae: Prospective anti-infective leads attenuate drug-resistant pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M
J Appl Microbiol; 2021 May; 130(5):1552-1570. PubMed ID: 33006801
[TBL] [Abstract][Full Text] [Related]
6. Difficidin class of polyketide antibiotics from marine macroalga-associated Bacillus as promising antibacterial agents.
Chakraborty K; Kizhakkekalam VK; Joy M; Dhara S
Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6395-6408. PubMed ID: 34415389
[TBL] [Abstract][Full Text] [Related]
7. Novel amylomacins from seaweed-associated Bacillus amyloliquefaciens as prospective antimicrobial leads attenuating resistant bacteria.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
World J Microbiol Biotechnol; 2021 Oct; 37(12):200. PubMed ID: 34664128
[TBL] [Abstract][Full Text] [Related]
8. Marine macroalga-associated heterotrophic Bacillus velezensis: a novel antimicrobial agent with siderophore mode of action against drug-resistant nosocomial pathogens.
Chakraborty K; Francis A; Chakraborty RD; Asharaf S; Kizhakkekalam VK; Paulose SK
Arch Microbiol; 2021 Nov; 203(9):5561-5575. PubMed ID: 34436634
[TBL] [Abstract][Full Text] [Related]
9. Marine macroalgae-associated heterotrophic Firmicutes and Gamma-proteobacteria: prospective anti-infective agents against multidrug resistant pathogens.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2020 May; 202(4):905-920. PubMed ID: 31897537
[TBL] [Abstract][Full Text] [Related]
10. Direct Antibiotic Activity of Bacillibactin Broadens the Biocontrol Range of Bacillus amyloliquefaciens MBI600.
Dimopoulou A; Theologidis I; Benaki D; Koukounia M; Zervakou A; Tzima A; Diallinas G; Hatzinikolaou DG; Skandalis N
mSphere; 2021 Aug; 6(4):e0037621. PubMed ID: 34378986
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-active heterotrophic Firmicutes sheltered in seaweeds: can they add new dimensions to future antimicrobial agents?
Chakraborty K; Varghese C; Asharaf S; Chakraborty RD
Arch Microbiol; 2022 Feb; 204(3):183. PubMed ID: 35179656
[TBL] [Abstract][Full Text] [Related]
12. Seaweed-associated heterotrophic bacteria: new paradigm of prospective anti-infective and anticancer agents.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2021 Apr; 203(3):1241-1250. PubMed ID: 33140140
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of marine macroalgae-associated heterotrophic bacteria.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2019 May; 201(4):505-518. PubMed ID: 30406296
[TBL] [Abstract][Full Text] [Related]
14. Chemical mining of heterotrophic Shewanella algae reveals anti-infective potential of macrocyclic polyketides against multidrug-resistant pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M
Bioorg Chem; 2021 Mar; 108():104533. PubMed ID: 33342567
[TBL] [Abstract][Full Text] [Related]
15. A Leap Forward Towards Unraveling Newer Anti-infective Agents from an Unconventional Source: a Draft Genome Sequence Illuminating the Future Promise of Marine Heterotrophic Bacillus sp. Against Drug-Resistant Pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Mar Biotechnol (NY); 2021 Oct; 23(5):790-808. PubMed ID: 34523054
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial aryl-crowned polyketide from Bacillus subtilis associated with seaweed Anthophycus longifolius.
Chakraborty K; Thilakan B; Kizhakkekalam VK
J Appl Microbiol; 2018 Jan; 124(1):108-125. PubMed ID: 29108108
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor Spo0A Regulates the Biosynthesis of Difficidin in Bacillus amyloliquefaciens.
Liu N; Sun H; Tang Z; Zheng Y; Qi G; Zhao X
Microbiol Spectr; 2023 Aug; 11(4):e0104423. PubMed ID: 37432122
[TBL] [Abstract][Full Text] [Related]
18. Seaweed-associated heterotrophic bacteria: are they future novel sources of antimicrobial agents against drug-resistant pathogens?
Asharaf S; Chakraborty K; Chakraborty RD
Arch Microbiol; 2022 Mar; 204(4):232. PubMed ID: 35355132
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial and wound healing potential of topical formulation of marine symbiotic Bacillus.
Kizhakkekalam VK; Chakraborty K; Krishnan S
Arch Microbiol; 2022 Sep; 204(10):648. PubMed ID: 36166149
[TBL] [Abstract][Full Text] [Related]
20. Bacillusin A, an Antibacterial Macrodiolide from Bacillus amyloliquefaciens AP183.
Ravu RR; Jacob MR; Chen X; Wang M; Nasrin S; Kloepper JW; Liles MR; Mead DA; Khan IA; Li XC
J Nat Prod; 2015 Apr; 78(4):924-8. PubMed ID: 25756620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
